Search for:

Home
About
Where we work
News
Strategies
Resources

8 June 2020

Phase I trial of LY-CoV555, an antibody against the COVID-19 spike protein is launched by Eli Lilly and Abcellera. Source

Return to the timeline

Keep in Touch

Our email newsletter has latest news on developments and campaign actions

Subscribe to our mailing list

Twitter

On the December 9, 2021, Network TBPeople, with technical support from 100% Life in #Ukraine and @ITPCglobal, submi… https://t.co/2yYHKk9UMp
2 days ago

Make Medicines Affordable Twitter

Instagram

This error message is only visible to WordPress admins

Error: No connected account.

Please go to the Instagram Feed settings page to connect an account.

Make Medicines Affordable Instagram

Facebook

Our rapid assessment and report has shown that recipients of care can usefully describe gaps in access to essential health services—including routine health screenings and testing services, medical care and treatment, and prevention and support services—and can showcase disparities in health and human rights.View the report here: itpcglobal.org/blog/resource/assessing-the-impact-of-covid19-on-people-living-with-hiv/ VNP+ National Forum Of PLHA Networks in Uganda Peduli Hati Bangsa ... See MoreSee Less

3 days ago ·

ITPC global Facebook

© Copyright ITPC 2022 Cookies Media enquiries Contact us Website by Maraid Design